nodes	percent_of_prediction	percent_of_DWPC	metapath
Brimonidine—Clonidine—SLC22A3—coronary artery disease	0.00298	1	CrCbGaD
Brimonidine—Hypersensitivity—Simvastatin—coronary artery disease	0.00032	0.000479	CcSEcCtD
Brimonidine—Insomnia—Perindopril—coronary artery disease	0.00032	0.000479	CcSEcCtD
Brimonidine—Asthenia—Eplerenone—coronary artery disease	0.00032	0.000479	CcSEcCtD
Brimonidine—Mental disorder—Lisinopril—coronary artery disease	0.000318	0.000476	CcSEcCtD
Brimonidine—Paraesthesia—Perindopril—coronary artery disease	0.000317	0.000475	CcSEcCtD
Brimonidine—Nausea—Acetylsalicylic acid—coronary artery disease	0.000316	0.000473	CcSEcCtD
Brimonidine—Erythema—Lisinopril—coronary artery disease	0.000316	0.000473	CcSEcCtD
Brimonidine—Pruritus—Eplerenone—coronary artery disease	0.000315	0.000472	CcSEcCtD
Brimonidine—Dyspnoea—Perindopril—coronary artery disease	0.000315	0.000472	CcSEcCtD
Brimonidine—Dizziness—Fenofibrate—coronary artery disease	0.000314	0.000471	CcSEcCtD
Brimonidine—Somnolence—Perindopril—coronary artery disease	0.000314	0.000471	CcSEcCtD
Brimonidine—Fatigue—Captopril—coronary artery disease	0.000314	0.00047	CcSEcCtD
Brimonidine—Syncope—Ramipril—coronary artery disease	0.000312	0.000468	CcSEcCtD
Brimonidine—Asthenia—Simvastatin—coronary artery disease	0.000312	0.000467	CcSEcCtD
Brimonidine—Dyspepsia—Perindopril—coronary artery disease	0.000311	0.000466	CcSEcCtD
Brimonidine—Hypotension—Losartan—coronary artery disease	0.00031	0.000464	CcSEcCtD
Brimonidine—Dysgeusia—Lisinopril—coronary artery disease	0.000309	0.000463	CcSEcCtD
Brimonidine—Dizziness—Clopidogrel—coronary artery disease	0.000309	0.000463	CcSEcCtD
Brimonidine—Paraesthesia—Furosemide—coronary artery disease	0.000309	0.000462	CcSEcCtD
Brimonidine—Palpitations—Ramipril—coronary artery disease	0.000308	0.000461	CcSEcCtD
Brimonidine—Pruritus—Simvastatin—coronary artery disease	0.000307	0.00046	CcSEcCtD
Brimonidine—Dizziness—Lovastatin—coronary artery disease	0.000307	0.00046	CcSEcCtD
Brimonidine—Loss of consciousness—Ramipril—coronary artery disease	0.000306	0.000459	CcSEcCtD
Brimonidine—Somnolence—Furosemide—coronary artery disease	0.000306	0.000458	CcSEcCtD
Brimonidine—Syncope—Timolol—coronary artery disease	0.000305	0.000457	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Perindopril—coronary artery disease	0.000305	0.000457	CcSEcCtD
Brimonidine—Fatigue—Perindopril—coronary artery disease	0.000305	0.000456	CcSEcCtD
Brimonidine—Cough—Ramipril—coronary artery disease	0.000304	0.000455	CcSEcCtD
Brimonidine—Pain—Perindopril—coronary artery disease	0.000302	0.000453	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Losartan—coronary artery disease	0.000302	0.000452	CcSEcCtD
Brimonidine—Hypersensitivity—Valsartan—coronary artery disease	0.000302	0.000452	CcSEcCtD
Brimonidine—Dizziness—Ezetimibe—coronary artery disease	0.000301	0.000451	CcSEcCtD
Brimonidine—Palpitations—Timolol—coronary artery disease	0.000301	0.000451	CcSEcCtD
Brimonidine—Insomnia—Losartan—coronary artery disease	0.0003	0.000449	CcSEcCtD
Brimonidine—Rash—Fenofibrate—coronary artery disease	0.0003	0.000449	CcSEcCtD
Brimonidine—Dermatitis—Fenofibrate—coronary artery disease	0.000299	0.000448	CcSEcCtD
Brimonidine—Loss of consciousness—Timolol—coronary artery disease	0.000299	0.000448	CcSEcCtD
Brimonidine—Headache—Fenofibrate—coronary artery disease	0.000298	0.000446	CcSEcCtD
Brimonidine—Vision blurred—Lisinopril—coronary artery disease	0.000298	0.000446	CcSEcCtD
Brimonidine—Paraesthesia—Losartan—coronary artery disease	0.000298	0.000446	CcSEcCtD
Brimonidine—Cough—Timolol—coronary artery disease	0.000297	0.000445	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000297	0.000444	CcSEcCtD
Brimonidine—Chest pain—Ramipril—coronary artery disease	0.000297	0.000444	CcSEcCtD
Brimonidine—Arthralgia—Ramipril—coronary artery disease	0.000297	0.000444	CcSEcCtD
Brimonidine—Myalgia—Ramipril—coronary artery disease	0.000297	0.000444	CcSEcCtD
Brimonidine—Fatigue—Furosemide—coronary artery disease	0.000296	0.000444	CcSEcCtD
Brimonidine—Dyspnoea—Losartan—coronary artery disease	0.000296	0.000443	CcSEcCtD
Brimonidine—Anxiety—Ramipril—coronary artery disease	0.000296	0.000443	CcSEcCtD
Brimonidine—Somnolence—Losartan—coronary artery disease	0.000295	0.000441	CcSEcCtD
Brimonidine—Dizziness—Eplerenone—coronary artery disease	0.000295	0.000441	CcSEcCtD
Brimonidine—Rash—Clopidogrel—coronary artery disease	0.000295	0.000441	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000295	0.000441	CcSEcCtD
Brimonidine—Dermatitis—Clopidogrel—coronary artery disease	0.000294	0.000441	CcSEcCtD
Brimonidine—Asthenia—Valsartan—coronary artery disease	0.000294	0.000441	CcSEcCtD
Brimonidine—Hypertension—Timolol—coronary artery disease	0.000294	0.00044	CcSEcCtD
Brimonidine—Pain—Furosemide—coronary artery disease	0.000294	0.00044	CcSEcCtD
Brimonidine—Hypersensitivity—Niacin—coronary artery disease	0.000294	0.00044	CcSEcCtD
Brimonidine—Discomfort—Ramipril—coronary artery disease	0.000293	0.000439	CcSEcCtD
Brimonidine—Asthenia—Olmesartan—coronary artery disease	0.000293	0.000438	CcSEcCtD
Brimonidine—Headache—Clopidogrel—coronary artery disease	0.000293	0.000438	CcSEcCtD
Brimonidine—Rash—Lovastatin—coronary artery disease	0.000293	0.000438	CcSEcCtD
Brimonidine—Dermatitis—Lovastatin—coronary artery disease	0.000292	0.000438	CcSEcCtD
Brimonidine—Dyspepsia—Losartan—coronary artery disease	0.000292	0.000437	CcSEcCtD
Brimonidine—Headache—Lovastatin—coronary artery disease	0.000291	0.000435	CcSEcCtD
Brimonidine—Pruritus—Valsartan—coronary artery disease	0.00029	0.000434	CcSEcCtD
Brimonidine—Dry mouth—Ramipril—coronary artery disease	0.00029	0.000434	CcSEcCtD
Brimonidine—Myalgia—Timolol—coronary artery disease	0.00029	0.000434	CcSEcCtD
Brimonidine—Chest pain—Timolol—coronary artery disease	0.00029	0.000434	CcSEcCtD
Brimonidine—Arthralgia—Timolol—coronary artery disease	0.00029	0.000434	CcSEcCtD
Brimonidine—Hypersensitivity—Pravastatin—coronary artery disease	0.000289	0.000433	CcSEcCtD
Brimonidine—Anxiety—Timolol—coronary artery disease	0.000289	0.000433	CcSEcCtD
Brimonidine—Pruritus—Olmesartan—coronary artery disease	0.000289	0.000432	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000288	0.000431	CcSEcCtD
Brimonidine—Dizziness—Simvastatin—coronary artery disease	0.000287	0.00043	CcSEcCtD
Brimonidine—Rash—Ezetimibe—coronary artery disease	0.000287	0.00043	CcSEcCtD
Brimonidine—Dermatitis—Ezetimibe—coronary artery disease	0.000287	0.00043	CcSEcCtD
Brimonidine—Discomfort—Timolol—coronary artery disease	0.000286	0.000429	CcSEcCtD
Brimonidine—Asthenia—Niacin—coronary artery disease	0.000286	0.000428	CcSEcCtD
Brimonidine—Fatigue—Losartan—coronary artery disease	0.000286	0.000428	CcSEcCtD
Brimonidine—Headache—Ezetimibe—coronary artery disease	0.000285	0.000427	CcSEcCtD
Brimonidine—Oedema—Ramipril—coronary artery disease	0.000284	0.000426	CcSEcCtD
Brimonidine—Dry mouth—Timolol—coronary artery disease	0.000284	0.000425	CcSEcCtD
Brimonidine—Pain—Losartan—coronary artery disease	0.000284	0.000425	CcSEcCtD
Brimonidine—Syncope—Lisinopril—coronary artery disease	0.000283	0.000424	CcSEcCtD
Brimonidine—Nausea—Fenofibrate—coronary artery disease	0.000282	0.000423	CcSEcCtD
Brimonidine—Pruritus—Niacin—coronary artery disease	0.000282	0.000422	CcSEcCtD
Brimonidine—Asthenia—Pravastatin—coronary artery disease	0.000282	0.000422	CcSEcCtD
Brimonidine—Rash—Eplerenone—coronary artery disease	0.000281	0.000421	CcSEcCtD
Brimonidine—Hypersensitivity—Trandolapril—coronary artery disease	0.000281	0.000421	CcSEcCtD
Brimonidine—Dermatitis—Eplerenone—coronary artery disease	0.000281	0.00042	CcSEcCtD
Brimonidine—Shock—Ramipril—coronary artery disease	0.00028	0.000419	CcSEcCtD
Brimonidine—Hypersensitivity—Enalapril—coronary artery disease	0.00028	0.000419	CcSEcCtD
Brimonidine—Palpitations—Lisinopril—coronary artery disease	0.000279	0.000418	CcSEcCtD
Brimonidine—Headache—Eplerenone—coronary artery disease	0.000279	0.000418	CcSEcCtD
Brimonidine—Nervous system disorder—Ramipril—coronary artery disease	0.000279	0.000418	CcSEcCtD
Brimonidine—Oedema—Timolol—coronary artery disease	0.000278	0.000416	CcSEcCtD
Brimonidine—Pruritus—Pravastatin—coronary artery disease	0.000278	0.000416	CcSEcCtD
Brimonidine—Loss of consciousness—Lisinopril—coronary artery disease	0.000278	0.000416	CcSEcCtD
Brimonidine—Nausea—Clopidogrel—coronary artery disease	0.000278	0.000416	CcSEcCtD
Brimonidine—Tachycardia—Ramipril—coronary artery disease	0.000278	0.000416	CcSEcCtD
Brimonidine—Skin disorder—Ramipril—coronary artery disease	0.000276	0.000414	CcSEcCtD
Brimonidine—Infection—Timolol—coronary artery disease	0.000276	0.000414	CcSEcCtD
Brimonidine—Hypersensitivity—Telmisartan—coronary artery disease	0.000276	0.000413	CcSEcCtD
Brimonidine—Cough—Lisinopril—coronary artery disease	0.000276	0.000413	CcSEcCtD
Brimonidine—Nausea—Lovastatin—coronary artery disease	0.000276	0.000413	CcSEcCtD
Brimonidine—Rash—Simvastatin—coronary artery disease	0.000274	0.00041	CcSEcCtD
Brimonidine—Dermatitis—Simvastatin—coronary artery disease	0.000273	0.00041	CcSEcCtD
Brimonidine—Asthenia—Trandolapril—coronary artery disease	0.000273	0.00041	CcSEcCtD
Brimonidine—Shock—Timolol—coronary artery disease	0.000273	0.00041	CcSEcCtD
Brimonidine—Nervous system disorder—Timolol—coronary artery disease	0.000273	0.000408	CcSEcCtD
Brimonidine—Asthenia—Enalapril—coronary artery disease	0.000272	0.000408	CcSEcCtD
Brimonidine—Headache—Simvastatin—coronary artery disease	0.000272	0.000407	CcSEcCtD
Brimonidine—Dizziness—Valsartan—coronary artery disease	0.000271	0.000406	CcSEcCtD
Brimonidine—Nausea—Ezetimibe—coronary artery disease	0.00027	0.000405	CcSEcCtD
Brimonidine—Skin disorder—Timolol—coronary artery disease	0.00027	0.000404	CcSEcCtD
Brimonidine—Dizziness—Olmesartan—coronary artery disease	0.00027	0.000404	CcSEcCtD
Brimonidine—Pruritus—Trandolapril—coronary artery disease	0.00027	0.000404	CcSEcCtD
Brimonidine—Arthralgia—Lisinopril—coronary artery disease	0.000269	0.000403	CcSEcCtD
Brimonidine—Chest pain—Lisinopril—coronary artery disease	0.000269	0.000403	CcSEcCtD
Brimonidine—Myalgia—Lisinopril—coronary artery disease	0.000269	0.000403	CcSEcCtD
Brimonidine—Asthenia—Telmisartan—coronary artery disease	0.000269	0.000402	CcSEcCtD
Brimonidine—Pruritus—Enalapril—coronary artery disease	0.000269	0.000402	CcSEcCtD
Brimonidine—Anxiety—Lisinopril—coronary artery disease	0.000268	0.000401	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.000267	0.0004	CcSEcCtD
Brimonidine—Discomfort—Lisinopril—coronary artery disease	0.000266	0.000398	CcSEcCtD
Brimonidine—Hypotension—Ramipril—coronary artery disease	0.000266	0.000398	CcSEcCtD
Brimonidine—Pruritus—Telmisartan—coronary artery disease	0.000265	0.000397	CcSEcCtD
Brimonidine—Nausea—Eplerenone—coronary artery disease	0.000265	0.000396	CcSEcCtD
Brimonidine—Dizziness—Niacin—coronary artery disease	0.000264	0.000395	CcSEcCtD
Brimonidine—Dry mouth—Lisinopril—coronary artery disease	0.000263	0.000394	CcSEcCtD
Brimonidine—Asthenia—Captopril—coronary artery disease	0.000261	0.000391	CcSEcCtD
Brimonidine—Hypotension—Timolol—coronary artery disease	0.00026	0.000389	CcSEcCtD
Brimonidine—Dizziness—Pravastatin—coronary artery disease	0.00026	0.000389	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.000259	0.000388	CcSEcCtD
Brimonidine—Rash—Valsartan—coronary artery disease	0.000259	0.000387	CcSEcCtD
Brimonidine—Dermatitis—Valsartan—coronary artery disease	0.000258	0.000387	CcSEcCtD
Brimonidine—Nausea—Simvastatin—coronary artery disease	0.000258	0.000386	CcSEcCtD
Brimonidine—Oedema—Lisinopril—coronary artery disease	0.000258	0.000386	CcSEcCtD
Brimonidine—Pruritus—Captopril—coronary artery disease	0.000258	0.000386	CcSEcCtD
Brimonidine—Rash—Olmesartan—coronary artery disease	0.000257	0.000385	CcSEcCtD
Brimonidine—Insomnia—Ramipril—coronary artery disease	0.000257	0.000385	CcSEcCtD
Brimonidine—Dermatitis—Olmesartan—coronary artery disease	0.000257	0.000385	CcSEcCtD
Brimonidine—Headache—Valsartan—coronary artery disease	0.000257	0.000385	CcSEcCtD
Brimonidine—Infection—Lisinopril—coronary artery disease	0.000256	0.000384	CcSEcCtD
Brimonidine—Headache—Olmesartan—coronary artery disease	0.000256	0.000383	CcSEcCtD
Brimonidine—Paraesthesia—Ramipril—coronary artery disease	0.000255	0.000382	CcSEcCtD
Brimonidine—Shock—Lisinopril—coronary artery disease	0.000254	0.00038	CcSEcCtD
Brimonidine—Asthenia—Perindopril—coronary artery disease	0.000254	0.00038	CcSEcCtD
Brimonidine—Dyspnoea—Ramipril—coronary artery disease	0.000253	0.00038	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000253	0.000379	CcSEcCtD
Brimonidine—Hypersensitivity—Furosemide—coronary artery disease	0.000253	0.000379	CcSEcCtD
Brimonidine—Somnolence—Ramipril—coronary artery disease	0.000253	0.000379	CcSEcCtD
Brimonidine—Dizziness—Trandolapril—coronary artery disease	0.000252	0.000377	CcSEcCtD
Brimonidine—Tachycardia—Lisinopril—coronary artery disease	0.000252	0.000377	CcSEcCtD
Brimonidine—Insomnia—Timolol—coronary artery disease	0.000251	0.000377	CcSEcCtD
Brimonidine—Rash—Niacin—coronary artery disease	0.000251	0.000376	CcSEcCtD
Brimonidine—Dermatitis—Niacin—coronary artery disease	0.000251	0.000376	CcSEcCtD
Brimonidine—Dizziness—Enalapril—coronary artery disease	0.000251	0.000376	CcSEcCtD
Brimonidine—Skin disorder—Lisinopril—coronary artery disease	0.00025	0.000375	CcSEcCtD
Brimonidine—Dyspepsia—Ramipril—coronary artery disease	0.00025	0.000375	CcSEcCtD
Brimonidine—Pruritus—Perindopril—coronary artery disease	0.00025	0.000375	CcSEcCtD
Brimonidine—Headache—Niacin—coronary artery disease	0.00025	0.000374	CcSEcCtD
Brimonidine—Paraesthesia—Timolol—coronary artery disease	0.00025	0.000374	CcSEcCtD
Brimonidine—Dyspnoea—Timolol—coronary artery disease	0.000248	0.000371	CcSEcCtD
Brimonidine—Dizziness—Telmisartan—coronary artery disease	0.000248	0.000371	CcSEcCtD
Brimonidine—Rash—Pravastatin—coronary artery disease	0.000247	0.000371	CcSEcCtD
Brimonidine—Dermatitis—Pravastatin—coronary artery disease	0.000247	0.00037	CcSEcCtD
Brimonidine—Somnolence—Timolol—coronary artery disease	0.000247	0.00037	CcSEcCtD
Brimonidine—Asthenia—Furosemide—coronary artery disease	0.000247	0.000369	CcSEcCtD
Brimonidine—Headache—Pravastatin—coronary artery disease	0.000246	0.000368	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000245	0.000368	CcSEcCtD
Brimonidine—Fatigue—Ramipril—coronary artery disease	0.000245	0.000367	CcSEcCtD
Brimonidine—Dyspepsia—Timolol—coronary artery disease	0.000245	0.000366	CcSEcCtD
Brimonidine—Hypersensitivity—Losartan—coronary artery disease	0.000244	0.000366	CcSEcCtD
Brimonidine—Nausea—Valsartan—coronary artery disease	0.000244	0.000365	CcSEcCtD
Brimonidine—Pruritus—Furosemide—coronary artery disease	0.000243	0.000364	CcSEcCtD
Brimonidine—Nausea—Olmesartan—coronary artery disease	0.000242	0.000363	CcSEcCtD
Brimonidine—Hypotension—Lisinopril—coronary artery disease	0.000241	0.000361	CcSEcCtD
Brimonidine—Dizziness—Captopril—coronary artery disease	0.000241	0.000361	CcSEcCtD
Brimonidine—Rash—Trandolapril—coronary artery disease	0.00024	0.00036	CcSEcCtD
Brimonidine—Dermatitis—Trandolapril—coronary artery disease	0.00024	0.00036	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Timolol—coronary artery disease	0.00024	0.000359	CcSEcCtD
Brimonidine—Fatigue—Timolol—coronary artery disease	0.00024	0.000359	CcSEcCtD
Brimonidine—Rash—Enalapril—coronary artery disease	0.000239	0.000358	CcSEcCtD
Brimonidine—Dermatitis—Enalapril—coronary artery disease	0.000239	0.000358	CcSEcCtD
Brimonidine—Headache—Trandolapril—coronary artery disease	0.000239	0.000358	CcSEcCtD
Brimonidine—Asthenia—Losartan—coronary artery disease	0.000238	0.000356	CcSEcCtD
Brimonidine—Headache—Enalapril—coronary artery disease	0.000238	0.000356	CcSEcCtD
Brimonidine—Pain—Timolol—coronary artery disease	0.000238	0.000356	CcSEcCtD
Brimonidine—Nausea—Niacin—coronary artery disease	0.000237	0.000355	CcSEcCtD
Brimonidine—Rash—Telmisartan—coronary artery disease	0.000236	0.000354	CcSEcCtD
Brimonidine—Dermatitis—Telmisartan—coronary artery disease	0.000236	0.000353	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Lisinopril—coronary artery disease	0.000235	0.000352	CcSEcCtD
Brimonidine—Pruritus—Losartan—coronary artery disease	0.000235	0.000351	CcSEcCtD
Brimonidine—Headache—Telmisartan—coronary artery disease	0.000235	0.000351	CcSEcCtD
Brimonidine—Dizziness—Perindopril—coronary artery disease	0.000234	0.00035	CcSEcCtD
Brimonidine—Insomnia—Lisinopril—coronary artery disease	0.000233	0.000349	CcSEcCtD
Brimonidine—Nausea—Pravastatin—coronary artery disease	0.000233	0.000349	CcSEcCtD
Brimonidine—Paraesthesia—Lisinopril—coronary artery disease	0.000232	0.000347	CcSEcCtD
Brimonidine—Dyspnoea—Lisinopril—coronary artery disease	0.00023	0.000344	CcSEcCtD
Brimonidine—Rash—Captopril—coronary artery disease	0.00023	0.000344	CcSEcCtD
Brimonidine—Dermatitis—Captopril—coronary artery disease	0.000229	0.000344	CcSEcCtD
Brimonidine—Somnolence—Lisinopril—coronary artery disease	0.000229	0.000343	CcSEcCtD
Brimonidine—Headache—Captopril—coronary artery disease	0.000228	0.000342	CcSEcCtD
Brimonidine—Dizziness—Furosemide—coronary artery disease	0.000227	0.00034	CcSEcCtD
Brimonidine—Dyspepsia—Lisinopril—coronary artery disease	0.000227	0.00034	CcSEcCtD
Brimonidine—Nausea—Trandolapril—coronary artery disease	0.000226	0.000339	CcSEcCtD
Brimonidine—Nausea—Enalapril—coronary artery disease	0.000226	0.000338	CcSEcCtD
Brimonidine—Rash—Perindopril—coronary artery disease	0.000223	0.000334	CcSEcCtD
Brimonidine—Dermatitis—Perindopril—coronary artery disease	0.000223	0.000334	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000223	0.000333	CcSEcCtD
Brimonidine—Nausea—Telmisartan—coronary artery disease	0.000222	0.000333	CcSEcCtD
Brimonidine—Fatigue—Lisinopril—coronary artery disease	0.000222	0.000333	CcSEcCtD
Brimonidine—Headache—Perindopril—coronary artery disease	0.000221	0.000332	CcSEcCtD
Brimonidine—Pain—Lisinopril—coronary artery disease	0.000221	0.00033	CcSEcCtD
Brimonidine—Dizziness—Losartan—coronary artery disease	0.000219	0.000328	CcSEcCtD
Brimonidine—Rash—Furosemide—coronary artery disease	0.000217	0.000325	CcSEcCtD
Brimonidine—Dermatitis—Furosemide—coronary artery disease	0.000216	0.000324	CcSEcCtD
Brimonidine—Nausea—Captopril—coronary artery disease	0.000216	0.000324	CcSEcCtD
Brimonidine—Headache—Furosemide—coronary artery disease	0.000215	0.000322	CcSEcCtD
Brimonidine—Nausea—Perindopril—coronary artery disease	0.00021	0.000314	CcSEcCtD
Brimonidine—Hypersensitivity—Ramipril—coronary artery disease	0.000209	0.000314	CcSEcCtD
Brimonidine—Rash—Losartan—coronary artery disease	0.000209	0.000313	CcSEcCtD
Brimonidine—Dermatitis—Losartan—coronary artery disease	0.000209	0.000313	CcSEcCtD
Brimonidine—Headache—Losartan—coronary artery disease	0.000208	0.000311	CcSEcCtD
Brimonidine—Hypersensitivity—Timolol—coronary artery disease	0.000205	0.000307	CcSEcCtD
Brimonidine—Nausea—Furosemide—coronary artery disease	0.000204	0.000306	CcSEcCtD
Brimonidine—Asthenia—Ramipril—coronary artery disease	0.000204	0.000306	CcSEcCtD
Brimonidine—Pruritus—Ramipril—coronary artery disease	0.000201	0.000301	CcSEcCtD
Brimonidine—Asthenia—Timolol—coronary artery disease	0.000199	0.000299	CcSEcCtD
Brimonidine—Nausea—Losartan—coronary artery disease	0.000197	0.000295	CcSEcCtD
Brimonidine—Pruritus—Timolol—coronary artery disease	0.000197	0.000295	CcSEcCtD
Brimonidine—Hypersensitivity—Lisinopril—coronary artery disease	0.00019	0.000285	CcSEcCtD
Brimonidine—Dizziness—Ramipril—coronary artery disease	0.000188	0.000282	CcSEcCtD
Brimonidine—Asthenia—Lisinopril—coronary artery disease	0.000185	0.000277	CcSEcCtD
Brimonidine—Dizziness—Timolol—coronary artery disease	0.000184	0.000275	CcSEcCtD
Brimonidine—Pruritus—Lisinopril—coronary artery disease	0.000182	0.000273	CcSEcCtD
Brimonidine—Rash—Ramipril—coronary artery disease	0.000179	0.000268	CcSEcCtD
Brimonidine—Dermatitis—Ramipril—coronary artery disease	0.000179	0.000268	CcSEcCtD
Brimonidine—Headache—Ramipril—coronary artery disease	0.000178	0.000267	CcSEcCtD
Brimonidine—Rash—Timolol—coronary artery disease	0.000175	0.000262	CcSEcCtD
Brimonidine—Dermatitis—Timolol—coronary artery disease	0.000175	0.000262	CcSEcCtD
Brimonidine—Headache—Timolol—coronary artery disease	0.000174	0.000261	CcSEcCtD
Brimonidine—Dizziness—Lisinopril—coronary artery disease	0.000171	0.000255	CcSEcCtD
Brimonidine—Nausea—Ramipril—coronary artery disease	0.000169	0.000253	CcSEcCtD
Brimonidine—Nausea—Timolol—coronary artery disease	0.000165	0.000247	CcSEcCtD
Brimonidine—Rash—Lisinopril—coronary artery disease	0.000163	0.000243	CcSEcCtD
Brimonidine—Dermatitis—Lisinopril—coronary artery disease	0.000162	0.000243	CcSEcCtD
Brimonidine—Headache—Lisinopril—coronary artery disease	0.000162	0.000242	CcSEcCtD
Brimonidine—Nausea—Lisinopril—coronary artery disease	0.000153	0.000229	CcSEcCtD
Brimonidine—ADRA2A—Signaling Pathways—DUSP6—coronary artery disease	2.94e-05	8.92e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PRKCE—coronary artery disease	2.91e-05	8.82e-05	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—JAK2—coronary artery disease	2.9e-05	8.82e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—CD36—coronary artery disease	2.9e-05	8.81e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—SOCS1—coronary artery disease	2.9e-05	8.8e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—S100B—coronary artery disease	2.89e-05	8.78e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PLAT—coronary artery disease	2.89e-05	8.77e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—PPP2CA—coronary artery disease	2.86e-05	8.7e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—SOCS3—coronary artery disease	2.86e-05	8.69e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—APOB—coronary artery disease	2.86e-05	8.69e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—PIK3CA—coronary artery disease	2.85e-05	8.65e-05	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—CXCL8—coronary artery disease	2.84e-05	8.61e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—KITLG—coronary artery disease	2.83e-05	8.59e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—TGFBR2—coronary artery disease	2.83e-05	8.59e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—JAK2—coronary artery disease	2.82e-05	8.57e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—EDN1—coronary artery disease	2.82e-05	8.55e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CCL5—coronary artery disease	2.79e-05	8.48e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CXCL12—coronary artery disease	2.79e-05	8.46e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—BDKRB2—coronary artery disease	2.79e-05	8.46e-05	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—POMC—coronary artery disease	2.78e-05	8.45e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—F2—coronary artery disease	2.77e-05	8.42e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—VEGFA—coronary artery disease	2.77e-05	8.4e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—MMP3—coronary artery disease	2.77e-05	8.4e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—STAT5A—coronary artery disease	2.77e-05	8.4e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—IL6ST—coronary artery disease	2.76e-05	8.39e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CSF2—coronary artery disease	2.75e-05	8.36e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—FGF1—coronary artery disease	2.75e-05	8.36e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—GSTP1—coronary artery disease	2.75e-05	8.35e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—MTHFR—coronary artery disease	2.75e-05	8.34e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—JUNB—coronary artery disease	2.73e-05	8.31e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—LPL—coronary artery disease	2.73e-05	8.3e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PLCB1—coronary artery disease	2.73e-05	8.28e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—PPARGC1A—coronary artery disease	2.72e-05	8.27e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—HMOX1—coronary artery disease	2.71e-05	8.23e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—RPS6KB1—coronary artery disease	2.71e-05	8.22e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—MEF2C—coronary artery disease	2.71e-05	8.22e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—CAT—coronary artery disease	2.67e-05	8.12e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—APOB—coronary artery disease	2.67e-05	8.12e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—HTR7—coronary artery disease	2.67e-05	8.1e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—PIK3CA—coronary artery disease	2.66e-05	8.08e-05	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—CXCL8—coronary artery disease	2.65e-05	8.05e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—ITGB3—coronary artery disease	2.64e-05	8.01e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—JAK2—coronary artery disease	2.64e-05	8.01e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—EDN1—coronary artery disease	2.63e-05	7.99e-05	CbGpPWpGaD
Brimonidine—AOX1—Disease—IL6—coronary artery disease	2.61e-05	7.94e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—AGT—coronary artery disease	2.61e-05	7.93e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CCL5—coronary artery disease	2.61e-05	7.93e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—APOB—coronary artery disease	2.6e-05	7.88e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—CXCL8—coronary artery disease	2.58e-05	7.82e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—FGF1—coronary artery disease	2.57e-05	7.81e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CSF2—coronary artery disease	2.57e-05	7.81e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—PPP2CA—coronary artery disease	2.56e-05	7.78e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—APOE—coronary artery disease	2.56e-05	7.77e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—LPL—coronary artery disease	2.55e-05	7.75e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—ITGAV—coronary artery disease	2.54e-05	7.72e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—TGFB1—coronary artery disease	2.54e-05	7.71e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—KNG1—coronary artery disease	2.53e-05	7.7e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—RPS6KB1—coronary artery disease	2.53e-05	7.68e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—MEF2C—coronary artery disease	2.53e-05	7.68e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—APOA1—coronary artery disease	2.53e-05	7.68e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—POMC—coronary artery disease	2.53e-05	7.67e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—CREB1—coronary artery disease	2.53e-05	7.67e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—GSTM1—coronary artery disease	2.53e-05	7.67e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—AGTR1—coronary artery disease	2.52e-05	7.65e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—PRKCD—coronary artery disease	2.52e-05	7.64e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—MAPK1—coronary artery disease	2.49e-05	7.56e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—LPL—coronary artery disease	2.48e-05	7.53e-05	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—PIK3CA—coronary artery disease	2.47e-05	7.51e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—CCL2—coronary artery disease	2.47e-05	7.51e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—IL6R—coronary artery disease	2.46e-05	7.48e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—ITGB3—coronary artery disease	2.46e-05	7.48e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—HTR2A—coronary artery disease	2.46e-05	7.48e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CXCL10—coronary artery disease	2.46e-05	7.48e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—C3—coronary artery disease	2.46e-05	7.47e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PLG—coronary artery disease	2.46e-05	7.46e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—GPX1—coronary artery disease	2.42e-05	7.34e-05	CbGpPWpGaD
Brimonidine—AOX1—Disease—AKT1—coronary artery disease	2.41e-05	7.33e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—CXCL8—coronary artery disease	2.41e-05	7.31e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PPP2CA—coronary artery disease	2.39e-05	7.27e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—ADRB2—coronary artery disease	2.39e-05	7.26e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PRKCE—coronary artery disease	2.36e-05	7.17e-05	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—JAK2—coronary artery disease	2.36e-05	7.16e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—CD36—coronary artery disease	2.36e-05	7.15e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—SOCS1—coronary artery disease	2.35e-05	7.15e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PRKCD—coronary artery disease	2.35e-05	7.14e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—S100B—coronary artery disease	2.35e-05	7.13e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—HIF1A—coronary artery disease	2.35e-05	7.12e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—AGT—coronary artery disease	2.34e-05	7.1e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—AKT1—coronary artery disease	2.33e-05	7.06e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—PPP2CA—coronary artery disease	2.33e-05	7.06e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—SOCS3—coronary artery disease	2.33e-05	7.06e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—HTR2A—coronary artery disease	2.3e-05	6.99e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—KITLG—coronary artery disease	2.3e-05	6.98e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—TGFBR2—coronary artery disease	2.3e-05	6.98e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—C3—coronary artery disease	2.3e-05	6.98e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—LEP—coronary artery disease	2.29e-05	6.95e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—APOE—coronary artery disease	2.29e-05	6.95e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—APOA1—coronary artery disease	2.26e-05	6.87e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—STAT5A—coronary artery disease	2.25e-05	6.82e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—MMP3—coronary artery disease	2.25e-05	6.82e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—KDR—coronary artery disease	2.24e-05	6.81e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—MTHFR—coronary artery disease	2.23e-05	6.78e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—MAPK14—coronary artery disease	2.23e-05	6.77e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—PPARG—coronary artery disease	2.23e-05	6.77e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—POMC—coronary artery disease	2.2e-05	6.67e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—HIF1A—coronary artery disease	2.19e-05	6.65e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—ESR1—coronary artery disease	2.19e-05	6.64e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—AGT—coronary artery disease	2.18e-05	6.63e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—AKT1—coronary artery disease	2.17e-05	6.6e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—APOB—coronary artery disease	2.17e-05	6.59e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—PIK3CA—coronary artery disease	2.16e-05	6.56e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—FN1—coronary artery disease	2.16e-05	6.56e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—F2—coronary artery disease	2.16e-05	6.56e-05	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—CXCL8—coronary artery disease	2.15e-05	6.54e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—IL6ST—coronary artery disease	2.15e-05	6.53e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—JAK2—coronary artery disease	2.14e-05	6.5e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—LEP—coronary artery disease	2.14e-05	6.5e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—APOE—coronary artery disease	2.14e-05	6.5e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—EDN1—coronary artery disease	2.14e-05	6.49e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—NFKBIA—coronary artery disease	2.13e-05	6.48e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—AGT—coronary artery disease	2.12e-05	6.44e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CCL5—coronary artery disease	2.12e-05	6.44e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—APOA1—coronary artery disease	2.11e-05	6.42e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—KDR—coronary artery disease	2.1e-05	6.36e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CSF2—coronary artery disease	2.09e-05	6.34e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—FGF1—coronary artery disease	2.09e-05	6.34e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—MAPK14—coronary artery disease	2.08e-05	6.32e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—APOE—coronary artery disease	2.08e-05	6.31e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—LPL—coronary artery disease	2.07e-05	6.29e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—KIT—coronary artery disease	2.07e-05	6.28e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—RPS6KB1—coronary artery disease	2.05e-05	6.24e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—MEF2C—coronary artery disease	2.05e-05	6.24e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—APOA1—coronary artery disease	2.05e-05	6.24e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—ESR1—coronary artery disease	2.04e-05	6.2e-05	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—AKT1—coronary artery disease	2.02e-05	6.13e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—F2—coronary artery disease	2.02e-05	6.13e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—FN1—coronary artery disease	2.02e-05	6.13e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—IL6ST—coronary artery disease	2.01e-05	6.1e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—ALB—coronary artery disease	2e-05	6.08e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—ITGB3—coronary artery disease	2e-05	6.08e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—NFKBIA—coronary artery disease	1.99e-05	6.05e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—GSK3B—coronary artery disease	1.98e-05	6.02e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—POMC—coronary artery disease	1.97e-05	5.97e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CREB1—coronary artery disease	1.97e-05	5.97e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—CXCL8—coronary artery disease	1.95e-05	5.94e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PPP2CA—coronary artery disease	1.94e-05	5.91e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—KIT—coronary artery disease	1.93e-05	5.86e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CCL2—coronary artery disease	1.92e-05	5.85e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—IL6R—coronary artery disease	1.92e-05	5.83e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—NOS3—coronary artery disease	1.92e-05	5.82e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PRKCD—coronary artery disease	1.91e-05	5.8e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—IGF1—coronary artery disease	1.89e-05	5.75e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—MAPK1—coronary artery disease	1.88e-05	5.72e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—HTR2A—coronary artery disease	1.87e-05	5.68e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—C3—coronary artery disease	1.87e-05	5.67e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—GSK3B—coronary artery disease	1.85e-05	5.63e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—POMC—coronary artery disease	1.84e-05	5.58e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CREB1—coronary artery disease	1.84e-05	5.58e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—PPARG—coronary artery disease	1.81e-05	5.5e-05	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—PIK3CA—coronary artery disease	1.8e-05	5.46e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CCL2—coronary artery disease	1.8e-05	5.46e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—SERPINE1—coronary artery disease	1.8e-05	5.46e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—IL6R—coronary artery disease	1.79e-05	5.44e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—POMC—coronary artery disease	1.78e-05	5.42e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—HIF1A—coronary artery disease	1.78e-05	5.4e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—AGT—coronary artery disease	1.77e-05	5.38e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—IGF1—coronary artery disease	1.77e-05	5.37e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—AKT1—coronary artery disease	1.76e-05	5.36e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—MAPK1—coronary artery disease	1.76e-05	5.34e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—PTGS2—coronary artery disease	1.75e-05	5.32e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—FGF2—coronary artery disease	1.74e-05	5.28e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—LEP—coronary artery disease	1.74e-05	5.28e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—APOE—coronary artery disease	1.74e-05	5.28e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—APOA1—coronary artery disease	1.72e-05	5.22e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—NOS3—coronary artery disease	1.72e-05	5.21e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—KDR—coronary artery disease	1.7e-05	5.17e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—MAPK14—coronary artery disease	1.69e-05	5.13e-05	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—PIK3CA—coronary artery disease	1.68e-05	5.1e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—SERPINE1—coronary artery disease	1.68e-05	5.1e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—JAK2—coronary artery disease	1.67e-05	5.06e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—ESR1—coronary artery disease	1.66e-05	5.04e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—F2—coronary artery disease	1.64e-05	4.98e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—FN1—coronary artery disease	1.64e-05	4.98e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—PIK3CA—coronary artery disease	1.63e-05	4.96e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—IL6ST—coronary artery disease	1.63e-05	4.96e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—ALB—coronary artery disease	1.63e-05	4.94e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—FGF2—coronary artery disease	1.62e-05	4.93e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—NFKBIA—coronary artery disease	1.62e-05	4.92e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—NOS3—coronary artery disease	1.6e-05	4.87e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—KIT—coronary artery disease	1.57e-05	4.76e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—JAK2—coronary artery disease	1.56e-05	4.73e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—NOS3—coronary artery disease	1.56e-05	4.73e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—PIK3CA—coronary artery disease	1.53e-05	4.64e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CXCL8—coronary artery disease	1.52e-05	4.62e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—GSK3B—coronary artery disease	1.5e-05	4.57e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—POMC—coronary artery disease	1.49e-05	4.53e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CREB1—coronary artery disease	1.49e-05	4.53e-05	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—AKT1—coronary artery disease	1.47e-05	4.46e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CCL2—coronary artery disease	1.46e-05	4.43e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CASP3—coronary artery disease	1.46e-05	4.42e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—IL6R—coronary artery disease	1.46e-05	4.42e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—IL6—coronary artery disease	1.45e-05	4.39e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—IGF1—coronary artery disease	1.44e-05	4.36e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—MAPK1—coronary artery disease	1.43e-05	4.34e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—PTGS2—coronary artery disease	1.42e-05	4.32e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CXCL8—coronary artery disease	1.42e-05	4.32e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CCND1—coronary artery disease	1.42e-05	4.31e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—MMP9—coronary artery disease	1.38e-05	4.18e-05	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—AKT1—coronary artery disease	1.37e-05	4.17e-05	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.37e-05	4.15e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—SERPINE1—coronary artery disease	1.36e-05	4.14e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CASP3—coronary artery disease	1.36e-05	4.13e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—IL6—coronary artery disease	1.35e-05	4.1e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—AKT1—coronary artery disease	1.33e-05	4.05e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CCND1—coronary artery disease	1.32e-05	4.02e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	1.32e-05	4.01e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	1.3e-05	3.95e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—MMP9—coronary artery disease	1.29e-05	3.9e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	1.27e-05	3.84e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—AKT1—coronary artery disease	1.25e-05	3.79e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	1.24e-05	3.77e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—VEGFA—coronary artery disease	1.24e-05	3.75e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	1.15e-05	3.51e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—VEGFA—coronary artery disease	1.15e-05	3.51e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—TGFB1—coronary artery disease	1.13e-05	3.44e-05	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	1.12e-05	3.39e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—MAPK1—coronary artery disease	1.11e-05	3.38e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	1.11e-05	3.36e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	1.1e-05	3.33e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—PIK3CA—coronary artery disease	1.08e-05	3.27e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	1.08e-05	3.27e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—TGFB1—coronary artery disease	1.06e-05	3.22e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	1.04e-05	3.17e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—MAPK1—coronary artery disease	1.04e-05	3.16e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	1.01e-05	3.08e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—PIK3CA—coronary artery disease	9.65e-06	2.93e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	9.38e-06	2.85e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PIK3CA—coronary artery disease	9.02e-06	2.74e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—AKT1—coronary artery disease	8.81e-06	2.68e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—PIK3CA—coronary artery disease	8.76e-06	2.66e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	8.61e-06	2.61e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—IL6—coronary artery disease	8.55e-06	2.6e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	8.44e-06	2.56e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—IL6—coronary artery disease	7.98e-06	2.42e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—AKT1—coronary artery disease	7.89e-06	2.39e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—AKT1—coronary artery disease	7.37e-06	2.24e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	7.32e-06	2.22e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—AKT1—coronary artery disease	7.16e-06	2.17e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—IL6—coronary artery disease	6.49e-06	1.97e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	5.98e-06	1.82e-05	CbGpPWpGaD
